Table 1.
Dysregulated miRNAs (FC ≤ 0.50 or FC ≥ 2.00, P < 1.92E-04; N = 39) in ESCCa,b
No. | miRNA | No.cases expressing miRNA | Median FC | P-value | Frequency distribution of cases by FC category | |||
---|---|---|---|---|---|---|---|---|
FC ≤ 0.50 | 0.50 < FC < 2.00 | FC ≥ 2.00 | ||||||
Down-regulated | 1 | hsa-miR-375 | 90 | 0.02 | 9.38E-13 | 0.82 | 0.11 | 0.07 |
2 | hsa-miR-139-5p | 112 | 0.14 | 7.30E-17 | 0.81 | 0.13 | 0.05 | |
3 | hsa-miR-133a | 113 | 0.19 | 1.18E-12 | 0.70 | 0.19 | 0.12 | |
4 | hsa-miR-133b | 111 | 0.20 | 1.52E-10 | 0.63 | 0.21 | 0.16 | |
5 | hsa-miR-885-5p | 86 | 0.27 | 2.26E-08 | 0.59 | 0.30 | 0.10 | |
6 | hsa-miR-145 | 112 | 0.29 | 1.04E-10 | 0.63 | 0.24 | 0.12 | |
7 | hsa-miR-486-5p | 112 | 0.29 | 4.13E-10 | 0.70 | 0.16 | 0.14 | |
8 | hsa-miR-204 | 99 | 0.30 | 7.02E-08 | 0.62 | 0.23 | 0.15 | |
9 | hsa-miR-203 | 107 | 0.31 | 1.11E-04 | 0.58 | 0.23 | 0.19 | |
10 | hsa-miR-30a* | 113 | 0.31 | 6.96E-14 | 0.65 | 0.28 | 0.07 | |
11 | hsa-miR-378* | 104 | 0.34 | 1.05E-09 | 0.62 | 0.28 | 0.11 | |
12 | hsa-let-7c | 113 | 0.36 | 1.58E-09 | 0.63 | 0.24 | 0.13 | |
13 | hsa-miR-23b | 112 | 0.36 | 4.80E-11 | 0.59 | 0.32 | 0.09 | |
14 | hsa-miR-125b | 112 | 0.37 | 7.66E-09 | 0.54 | 0.32 | 0.13 | |
15 | hsa-miR-422a | 113 | 0.39 | 4.39E-10 | 0.58 | 0.31 | 0.12 | |
16 | hsa-miR-149 | 113 | 0.40 | 2.64E-08 | 0.56 | 0.32 | 0.12 | |
17 | hsa-miR-26b* | 84 | 0.40 | 4.10E-07 | 0.60 | 0.27 | 0.13 | |
18 | hsa-miR-30e* | 113 | 0.40 | 1.88E-11 | 0.57 | 0.35 | 0.09 | |
19 | hsa-miR-99a* | 111 | 0.40 | 1.08E-07 | 0.59 | 0.24 | 0.16 | |
20 | hsa-miR-328 | 108 | 0.41 | 1.07E-09 | 0.59 | 0.31 | 0.10 | |
21 | hsa-miR-140-3p | 113 | 0.44 | 2.89E-11 | 0.57 | 0.36 | 0.07 | |
22 | hsa-miR-574–3p | 112 | 0.45 | 9.99E-10 | 0.53 | 0.38 | 0.09 | |
23 | hsa-miR-143 | 113 | 0.48 | 1.63E-07 | 0.51 | 0.35 | 0.13 | |
24 | hsa-miR-378 | 113 | 0.48 | 1.05E-09 | 0.51 | 0.38 | 0.11 | |
25 | hsa-miR-100 | 113 | 0.49 | 6.58E-07 | 0.50 | 0.39 | 0.11 | |
26 | hsa-miR-150 | 113 | 0.49 | 1.64E-11 | 0.50 | 0.44 | 0.05 | |
27 | hsa-miR-423-5p | 103 | 0.49 | 1.87E-04 | 0.50 | 0.29 | 0.20 | |
28 | hsa-miR-95 | 112 | 0.50 | 1.17E-06 | 0.50 | 0.38 | 0.12 | |
Up-regulated | 29 | hsa-miR-183* | 90 | 2.14 | 8.10E-07 | 0.12 | 0.33 | 0.54 |
30 | hsa-miR-106b | 109 | 2.24 | 3.62E-08 | 0.10 | 0.39 | 0.51 | |
31 | hsa-miR-708 | 110 | 2.29 | 3.46E-09 | 0.11 | 0.35 | 0.55 | |
32 | hsa-miR-22 | 98 | 2.39 | 4.77E-06 | 0.18 | 0.26 | 0.56 | |
33 | hsa-miR-639 | 83 | 2.44 | 1.30E-05 | 0.14 | 0.30 | 0.55 | |
34 | hsa-miR-21* | 110 | 2.69 | 3.64E-10 | 0.12 | 0.29 | 0.59 | |
35 | hsa-miR-596 | 94 | 2.72 | 6.48E-06 | 0.17 | 0.27 | 0.56 | |
36 | hsa-miR-130b | 94 | 2.78 | 2.72E-08 | 0.11 | 0.31 | 0.59 | |
37 | hsa-miR-124 | 100 | 2.98 | 7.20E-05 | 0.21 | 0.23 | 0.56 | |
38 | hsa-miR-21 | 112 | 4.60 | 0.00E+ 00 | 0.02 | 0.21 | 0.78 | |
39 | hsa-miR-196b | 104 | 9.31 | 2.22E-16 | 0.06 | 0.11 | 0.84 |
amiRs sorted by ascending tumor/normal median fold change (FC)
bP-value threshold for multiple comparison adjustment is P < 1.92E-04 (0.05/260)